85 related articles for article (PubMed ID: 16387188)
1. Alendronate for treatment of renal transplant patients with osteoporosis.
Chong C
Transplant Proc; 2005 Dec; 37(10):4639; author reply 4639. PubMed ID: 16387188
[No Abstract] [Full Text] [Related]
2. Alendronate is effective to treat bone loss in renal transplantation recipients.
Lan G; Peng L; Xie X; Peng F; Wang Y; Yu S
Transplant Proc; 2008 Dec; 40(10):3496-8. PubMed ID: 19100422
[TBL] [Abstract][Full Text] [Related]
3. Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis.
Gallagher JC; Rosen CJ; Chen P; Misurski DA; Marcus R
Bone; 2006 Dec; 39(6):1268-75. PubMed ID: 16884968
[TBL] [Abstract][Full Text] [Related]
4. Comparison of alendronate vs alendronate plus mechanical loading as prophylaxis for osteoporosis in lung transplant recipients: a pilot study.
Braith RW; Conner JA; Fulton MN; Lisor CF; Casey DP; Howe KS; Baz MA
J Heart Lung Transplant; 2007 Feb; 26(2):132-7. PubMed ID: 17258146
[TBL] [Abstract][Full Text] [Related]
5. [Alendronate treatment of osteoporosis secondary to Duchenne muscular dystrophy].
Palomo Atance E; Ballester Herrera MJ; Márquez de La Plata MA; Medina Cano E; Carmona Vilchez RM
An Pediatr (Barc); 2011 Feb; 74(2):122-5. PubMed ID: 21169073
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates are effective prophylactic of early bone loss after renal transplantation.
Nowacka-Cieciura E; Cieciura T; Baczkowska T; Kozińska-Przybył O; Tronina O; Chudziński W; Pacholczyk M; Durlik M
Transplant Proc; 2006; 38(1):165-7. PubMed ID: 16504693
[TBL] [Abstract][Full Text] [Related]
7. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
[TBL] [Abstract][Full Text] [Related]
8. Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.
Skordis N; Ioannou YS; Kyriakou A; Savva SC; Efstathiou E; Savvides I; Christou S
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():144-8. PubMed ID: 19337169
[TBL] [Abstract][Full Text] [Related]
9. Alendronate for treatment of renal transplant patients with osteoporosis.
Torregrosa JV; Moreno A; Gutierrez A; Vidal S; Oppenheimer F
Transplant Proc; 2003 Jun; 35(4):1393-5. PubMed ID: 12826169
[TBL] [Abstract][Full Text] [Related]
10. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
Rossi CM; Di Comite G
N Engl J Med; 2008 Mar; 358(12):1302; author reply 1303-4. PubMed ID: 18354112
[No Abstract] [Full Text] [Related]
11. Prevalence of osteoporosis, osteopenia, and vertebral fractures in long-term renal transplant recipients.
Marcén R; Caballero C; Uriol O; Fernández A; Villafruela JJ; Pascual J; Martins J; Rodriguez N; Burgos FJ; Ortuño J
Transplant Proc; 2007 Sep; 39(7):2256-8. PubMed ID: 17889156
[TBL] [Abstract][Full Text] [Related]
12. [Cost effective osteoporosis therapy. Alendronate is also immediately available as a generic drug].
MMW Fortschr Med; 2005 Dec; 147(49-50):74-5. PubMed ID: 16401016
[No Abstract] [Full Text] [Related]
13. [Alendronate for the prevention and treatment of postmenopausal osteoporosis. A survey of a Cochrane review].
Eiken PA; Abrahamsen B
Ugeskr Laeger; 2009 Mar; 171(11):903-6. PubMed ID: 19278615
[No Abstract] [Full Text] [Related]
14. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
Babb RR
N Engl J Med; 2008 Mar; 358(12):1302-3; author reply 1303-4. PubMed ID: 18357641
[No Abstract] [Full Text] [Related]
15. Effect of alendronate on early bone loss of renal transplant recipients.
Abediazar S; Nakhjavani MR
Transplant Proc; 2011 Mar; 43(2):565-7. PubMed ID: 21440762
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
Iwamoto J; Takeda T; Sato Y
Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
[TBL] [Abstract][Full Text] [Related]
17. [Progress for patients with osteoporosis].
MMW Fortschr Med; 2006 May; 148(20):56-7. PubMed ID: 16805195
[No Abstract] [Full Text] [Related]
18. [Alendronate].
Okazaki R
Clin Calcium; 2008 Oct; 18(10):1410-6. PubMed ID: 18830037
[TBL] [Abstract][Full Text] [Related]
19. Alendronate treatment in osteogenesis imperfecta.
Madenci E; Yilmaz K; Yilmaz M; Coskun Y
J Clin Rheumatol; 2006 Apr; 12(2):53-6. PubMed ID: 16601536
[TBL] [Abstract][Full Text] [Related]
20. Osteoporosis treatment in elderly hyperthyroid male patients.
Fittipaldi MR; Fonderico F; Vitale G; Ciccarelli A; Lupoli GA; Cascella T; Panico A; Lupoli G
J Endocrinol Invest; 2002; 25(10 Suppl):98-100. PubMed ID: 12508936
[No Abstract] [Full Text] [Related]
[Next] [New Search]
